WO2012011741A3 - 신규한 푸사리세틴 화합물 및 이의 용도 - Google Patents

신규한 푸사리세틴 화합물 및 이의 용도 Download PDF

Info

Publication number
WO2012011741A3
WO2012011741A3 PCT/KR2011/005348 KR2011005348W WO2012011741A3 WO 2012011741 A3 WO2012011741 A3 WO 2012011741A3 KR 2011005348 W KR2011005348 W KR 2011005348W WO 2012011741 A3 WO2012011741 A3 WO 2012011741A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
cancer cells
fusarisetin
novel
separated
Prior art date
Application number
PCT/KR2011/005348
Other languages
English (en)
French (fr)
Other versions
WO2012011741A2 (ko
WO2012011741A9 (ko
Inventor
안종석
장재혁
김보연
장준필
아사미유키히로
오현철
Original Assignee
한국생명공학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국생명공학연구원 filed Critical 한국생명공학연구원
Priority to CN201180045301.0A priority Critical patent/CN103443103B/zh
Priority to JP2013520651A priority patent/JP5728576B2/ja
Priority to US13/811,133 priority patent/US8916602B2/en
Publication of WO2012011741A2 publication Critical patent/WO2012011741A2/ko
Publication of WO2012011741A3 publication Critical patent/WO2012011741A3/ko
Publication of WO2012011741A9 publication Critical patent/WO2012011741A9/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

본 발명은 본 발명은 푸사리움 속 곰팡이(Fusarium sp.) FN080326로부터 분리한 항암활성을 갖는 신규한 푸사리세틴 화합물 및 이의 용도에 관한 것으로서, 보다 상세하게는 토양샘플에서 분리한 곰팡이 푸사리움 속(Fusarium sp.) FN080326로부터 분리 정제한 신규한 푸사리세틴 화합물들이 유방암 세포, 간암 세포 또는 골수성 백혈병 세포와 같은 암세포들에 대하여 증식저해 및 전이저해 활성을 가지고 있으므로, 상기 화합물들을 유효성분으로 함유하는 항암용 조성물로 유용하게 사용될 수 있다.
PCT/KR2011/005348 2010-07-20 2011-07-20 신규한 푸사리세틴 화합물 및 이의 용도 WO2012011741A2 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN201180045301.0A CN103443103B (zh) 2010-07-20 2011-07-20 新型Fusarisetin化合物及其用途
JP2013520651A JP5728576B2 (ja) 2010-07-20 2011-07-20 新規なフサリセチン化合物およびその用途
US13/811,133 US8916602B2 (en) 2010-07-20 2011-07-20 Fusarisetin compounds, and use thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2010-0070131 2010-07-20
KR20100070131 2010-07-20
KR10-2011-0072017 2011-07-20
KR1020110072017A KR101308539B1 (ko) 2010-07-20 2011-07-20 신규한 푸사리세틴 화합물 및 이의 용도

Publications (3)

Publication Number Publication Date
WO2012011741A2 WO2012011741A2 (ko) 2012-01-26
WO2012011741A3 true WO2012011741A3 (ko) 2012-05-18
WO2012011741A9 WO2012011741A9 (ko) 2012-07-05

Family

ID=45497299

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/005348 WO2012011741A2 (ko) 2010-07-20 2011-07-20 신규한 푸사리세틴 화합물 및 이의 용도

Country Status (5)

Country Link
US (1) US8916602B2 (ko)
JP (1) JP5728576B2 (ko)
KR (1) KR101308539B1 (ko)
CN (1) CN103443103B (ko)
WO (1) WO2012011741A2 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103524513A (zh) * 2013-09-26 2014-01-22 华东师范大学 两类3-酰基-2,4-吡咯烷-二酮类化合物及其合成方法
WO2019070087A1 (ko) * 2017-10-02 2019-04-11 한국생명공학연구원 푸사리세틴 화합물을 포함하는 피부 미백용 조성물
CN111196815B (zh) * 2019-05-08 2022-04-29 中国农业科学院烟草研究所 一种海洋真菌来源新型fusarisetin类除草剂、制备方法及应用
WO2024048755A1 (ja) * 2022-09-01 2024-03-07 島津ダイアグノスティクス株式会社 迅速無菌試験法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0986960A1 (en) * 1998-09-15 2000-03-22 Dsm N.V. Mucorales fungi for use in preparation of textured products for foodstuffs
JP2007535559A (ja) * 2004-04-30 2007-12-06 ネレアス ファーマシューティカルズ インコーポレイテッド ［３．２．０］複素環式化合物及びその使用法
CA2714793A1 (en) * 2008-02-14 2009-08-20 Barley & Oats Co., Ltd. Method for producing fermented product using natural material, and food or medicine containing fermented product made from same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BEZUIDENHOUT, S.C. ET AL.: "Structure elucidation of the fumonisins, mycotoxins from Fusarium moniliforme.", J. CHEM. SOC., CHEM. COMMUN., vol. 11, 1988, pages 743 - 745 *
BURKE,L.T. ET AL.: "A short stereoselective total synthesis of the fusarium toxin equisetin.", ORGANIC LETTERS., vol. 2, no. 23, 2000, pages 3611 - 3613 *
GELDERBLOM,W.C. ET AL.: "Fumonisins - novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme.", APPLIED & ENVIRONMENTAL MICROBIOLOGY., vol. 54, no. 7, 1988, pages 1806 - 1811 *
PEREIRA,C. ET AL.: "Total synthesis of the sphingolipid biosynthesis inhibitor fumonisin Bl.", J. AM. CHEM. SOC., vol. 131, 2009, pages 6066 - 6067 *

Also Published As

Publication number Publication date
JP5728576B2 (ja) 2015-06-03
CN103443103B (zh) 2016-06-22
US20130116297A1 (en) 2013-05-09
WO2012011741A2 (ko) 2012-01-26
US8916602B2 (en) 2014-12-23
CN103443103A (zh) 2013-12-11
JP2013534216A (ja) 2013-09-02
KR20120010175A (ko) 2012-02-02
WO2012011741A9 (ko) 2012-07-05
KR101308539B1 (ko) 2013-09-23

Similar Documents

Publication Publication Date Title
CA2871471C (en) Dna-pk inhibitors
PH12014502772A1 (en) Substituted tricyclic compounds as fgfr inhibitors
WO2011032169A3 (en) Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
WO2010041913A3 (ko) Grs 단백질 또는 이의 단편의 신규한 용도
MD20150043A2 (ro) Inhibitori ai histon-demetilazelor
WO2012046030A3 (en) Phosphodiesterase inhibitors
MX2013001970A (es) Compuestos de pirrolopirimidina y usos de los mismos.
MX2013004491A (es) Boronatos como inhibidores de arginasa.
WO2012104263A3 (en) 1,4 oxazines as bace1 and/or bace2 inhibitors
WO2011113060A3 (en) Antiviral compounds and methods of use thereof
WO2013057013A3 (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
WO2010147830A3 (en) Aminothiazole modulators of beta-3-adrenoreceptor
JO3611B1 (ar) سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
WO2011159129A3 (ko) 신규한 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 ａｉｄｓ 예방 또는 치료용 약학 조성물
WO2012162513A3 (en) Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase i inhibitors
WO2011149288A2 (ko) 복수의 타이로신 카이네이즈에 대한 저해 활성을 가지는 항염증 화합물 및 이를 포함하는 약학적 조성물
WO2012134169A3 (ko) 조각인 추출물을 포함하는 폐암 치료용 조성물 및 건강 기능성 식품
WO2012011741A3 (ko) 신규한 푸사리세틴 화합물 및 이의 용도
MX367309B (es) Nuevos compuestos antibacterianos.
MX2015001835A (es) Nuevos compuestos antibacterianos.
WO2010027458A3 (en) Pdk inhibitor compounds and methods of use thereof
WO2014047519A3 (en) Inhibitors of beta-hydrolase for treatment of cancer
WO2009097973A3 (de) Imidazopyridazine als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel
MX2013002398A (es) Inhibidores de beta-secretasa (base) para su uso en tratamiento de diabetes.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11809868

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2013520651

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13811133

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11809868

Country of ref document: EP

Kind code of ref document: A2